Moreover, their cognate ligands, including CCL2, CCL3, CCL4, CCL5, CXCL9, CXCL10, and CXCL11, are often upregulated in a range of different tumour types [29,30,31,32,33]. This evidence concerns the gene CXCL10 and neoplasm.